Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 67 Results

Title
Intervention Indication Therapeutic Area Year Actions
Lanadelumab for prevention of attacks in adults and adolescents with Type I and Type II hereditary angioedema Lanadelumab (SHP643; TAK-743; Takhzyro) Hereditary angioedema (HAE) Genetic Disorders , Immunology 2017 View  |  Download
Mavorixafor for WHIM syndrome Mavorixafor (X4P-001) WHIM syndrome Genetic Disorders , Immunology 2021 View  |  Download
Mepolizumab for hypereosinophilic syndrome – add-on therapy Mepolizumab (Nucala; SB-240563; SB-240563 autoinjector) Hypereosinophilic syndrome (HES) Immunology 2020 View  |  Download
Mirikizumab for treating moderately to severely active Crohn’s disease Mirikizumab (LY3074828) Crohn's disease Gastroenterology , Immunology 2022 View  |  Download
Nefecon (targeted-release budesonide formulation) for IgA Nephropathy (Berger's disease) Budesonide targeted-release (Nefecon; PL-56) IgA nephropathy Immunology , Nephrology 2018 View  |  Download
Obinutuzumab with mycophenolate mofetil for treating lupus nephritis Mycophenolate mofetil (Cellcept) , Obinutuzumab (Gazyvaro; RO5072759; GA101; Afutuzumab) Lupus nephritis Immunology , Nephrology 2023 View  |  Download
OTL-103 for Wiskott-Aldrich syndrome OTL-103 (GSK-2696275) Wiskott-Aldrich syndrome (WAS) Genetic Disorders , Immunology 2020 View  |  Download
Plinabulin in combination with G-CSF for chemotherapy-induced neutropenia Plinabulin (BPI-2358) Chemotherapy-induced neutropenia Immunology , Toxicology 2020 View  |  Download
Rilzabrutinib for treating persistent or chronic immune thrombocytopenia Rilzabrutinib Immune thrombocytopenia (ITP) Haematology , Immunology 2023 View  |  Download
Risankizumab for moderate to severe crohn’s disease Risankizumab (BI 655066; Skyrizi; ABBV 066) Crohn's disease Gastroenterology , Immunology 2021 View  |  Download
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications